Zobrazeno 1 - 10 of 1 717 pro vyhledávání: '"Chernyak, N."'
1
Akademický článek
The good, the rich, and the powerful: How young children compensate victims of moral transgressions depending on moral character, wealth, and social dominance.
Autor: Schwartz F; Laboratoire Cognition, Langues, Langage, Ergonomie (CLLE), Université de Toulouse, CNRS, 31058 Toulouse Cedex 9, France. Electronic address: flora.schwartz.pro@gmail.com., Chernyak N; Department of Cognitive Sciences, University of California, Irvine, Irvine, CA 92617, USA.
Publikováno v: Journal of experimental child psychology [J Exp Child Psychol] 2024 Nov; Vol. 247, pp. 106045. Date of Electronic Publication: 2024 Aug 20.
Zobrazit plný text záznamu
2
Akademický článek
Being nice by choice: The effect of counterfactual reasoning on children's social evaluations.
Autor: Wong A; Department of Psychology and Neuroscience, Boston College, Chestnut Hill, Massachusetts, USA., Cordes S; Department of Psychology and Neuroscience, Boston College, Chestnut Hill, Massachusetts, USA., Harris PL; Graduate School of Education, Harvard University, Cambridge, Massachusetts, USA., Chernyak N; Department of Cognitive Sciences, University of California Irvine, Irvine, California, USA.
Publikováno v: Developmental science [Dev Sci] 2023 Nov; Vol. 26 (6), pp. e13394. Date of Electronic Publication: 2023 Apr 19.
Zobrazit plný text záznamu
3
Akademický článek
Discovery and Evaluation of TLR-Targeted Immune Agonists.
Autor: Chernyak N; Discovery Chemistry, Merck & Co., Inc., South San Francisco, California 94080, United States., Bhagwat B; Discovery Biologics, Merck & Co., Inc., South San Francisco, California 94080, United States., Naravula S; Discovery Biologics, Merck & Co., Inc., South San Francisco, California 94080, United States., Chen Y; Pharmacokinetics, Dynamics, Metabolism and Bioanalytics, Merck & Co., Inc., South San Francisco, California 94080, United States., Solban N; Quantitative Biosciences, Merck & Co., Inc., Boston, Massachusetts 02115, United States., Zhang F; Discovery Biologics, Merck & Co., Inc., South San Francisco, California 94080, United States., Kofman E; Discovery Biologics, Merck & Co., Inc., South San Francisco, California 94080, United States., Raoufi F; Discovery Biologics, Merck & Co., Inc., South San Francisco, California 94080, United States., Dang X; Pharmacokinetics, Dynamics, Metabolism and Bioanalytics, Merck & Co., Inc., South San Francisco, California 94080, United States., Bao J; Discovery Chemistry, Merck & Co., Inc., South San Francisco, California 94080, United States., Tomazela D; Discovery Biologics, Merck & Co., Inc., South San Francisco, California 94080, United States., Baily M; Discovery Biologics, Merck & Co., Inc., South San Francisco, California 94080, United States., Geierstanger B; Discovery Biologics, Merck & Co., Inc., South San Francisco, California 94080, United States., Flygare JA; Discovery Chemistry, Merck & Co., Inc., South San Francisco, California 94080, United States., Han JH; Discovery Oncology, Merck & Co., Inc., South San Francisco, California 94080, United States., Willingham A; Discovery Biologics, Merck & Co., Inc., South San Francisco, California 94080, United States., Seganish WM; Discovery Chemistry, Merck & Co., Inc., South San Francisco, California 94080, United States.
Publikováno v: Journal of medicinal chemistry [J Med Chem] 2024 Sep 26; Vol. 67 (18), pp. 16222-16234. Date of Electronic Publication: 2024 Sep 05.
Zobrazit plný text záznamu
4
Akademický článek
Design and Optimization of Selectivity-Tunable Toll-like Receptor 7/8 Agonists as Novel Antibody-Drug Conjugate Payloads.
Autor: Patel AM; Discovery Chemistry, Merck & Co. Inc., South San Francisco, California 94080, United States., Willingham A; Discovery Biologics, Merck & Co. Inc., South San Francisco, California 94080, United States., Cheng AC; Modeling and Informatics, Merck & Co. Inc., South San Francisco, California 94080, United States., Tomazela D; Discovery Biologics, Merck & Co. Inc., South San Francisco, California 94080, United States., Bowman E; Discovery Oncology, Merck & Co. Inc., South San Francisco, California 94080, United States., Kofman E; Discovery Biologics, Merck & Co. Inc., South San Francisco, California 94080, United States., Zhang F; Discovery Biologics, Merck & Co. Inc., South San Francisco, California 94080, United States., Bao J; External Discovery Chemistry, Merck & Co. Inc., South San Francisco, California 94080, United States., Sanzone JR; External Discovery Chemistry, Merck & Co. Inc., South San Francisco, California 94080, United States., Choy JW; Discovery Oncology, Merck & Co. Inc., South San Francisco, California 94080, United States., Flygare JA; Discovery Chemistry, Merck & Co. Inc., South San Francisco, California 94080, United States., Han JH; Discovery Oncology, Merck & Co. Inc., South San Francisco, California 94080, United States., Pradhan K; Discovery Oncology, Merck & Co. Inc., South San Francisco, California 94080, United States., Kieffer M; Discovery Chemistry, Merck & Co. Inc., South San Francisco, California 94080, United States., Chernyak N; Discovery Chemistry, Merck & Co. Inc., South San Francisco, California 94080, United States., Akbari P; Discovery Oncology, Merck & Co. Inc., South San Francisco, California 94080, United States., Liu P; External Discovery Chemistry, Merck & Co. Inc., South San Francisco, California 94080, United States., Mehmood R; Modeling and Informatics, Merck & Co. Inc., South San Francisco, California 94080, United States., Naravula S; Discovery Biologics, Merck & Co. Inc., South San Francisco, California 94080, United States., Hollingsworth SA; Modeling and Informatics, Merck & Co. Inc., South San Francisco, California 94080, United States., Bhagwat B; Discovery Biologics, Merck & Co. Inc., South San Francisco, California 94080, United States., Lang SB; Discovery Chemistry, Merck & Co. Inc., South San Francisco, California 94080, United States., Seganish WM; Discovery Chemistry, Merck & Co. Inc., South San Francisco, California 94080, United States.
Publikováno v: Journal of medicinal chemistry [J Med Chem] 2024 Sep 12; Vol. 67 (17), pp. 15756-15779. Date of Electronic Publication: 2024 Aug 22.
Zobrazit plný text záznamu
5
Akademický článek
How do patients with diabetes report their comorbidity? Comparison with administrative data
Autor: Hoffmann J, Haastert B, Brüne M, Kaltheuner M, Begun A, Chernyak N, Icks A
Publikováno v: Clinical Epidemiology, Vol Volume 10, Pp 499-509 (2018)
Jonas Hoffmann,1,* Burkhard Haastert,2,* Manuela Brüne,1 Matthias Kaltheuner,3 Alexander Begun,1 Nadja Chernyak,4 Andrea Icks1,4,5 1Institute of Health Services Research and Health Economics, German Diabetes Center, Düsseldorf, Germany; 2mediStatis
Externí odkaz: https://doaj.org/article/a64c1b310931498398e945d2d470908f
Zobrazit plný text záznamu
6
Akademický článek
Assessment of information needs in diabetes: Development and evaluation of a questionnaire
Autor: Chernyak, N., Stephan, A., Bächle, C., Genz, J., Jülich, F., Icks, A.
Publikováno v: In Primary Care Diabetes August 2016 10(4):287-292
Zobrazit plný text záznamu
7
PHQ-9, CES-D, health insurance data—who is identified with depression? A Population-based study in persons with diabetes
Autor: Linnenkamp, U., Gontscharuk, V., Ogurtsova, K., Brune, M., Chernyak, N., Kvitkina, T., Arend, W., Schmitz-Losem, I., Kruse, J., Hermanns, N., Kulzer, B., Evers, S.M.A.A., Hiligsmann, M., Hoffmann, B., Icks, A., Andrich, S.
Publikováno v: Diabetology & Metabolic Syndrome, 15(1):54. BioMed Central Ltd
Aims Several instruments are used to identify depression among patients with diabetes and have been compared for their test criteria, but, not for the overlaps and differences, for example, in the sociodemographic and clinical characteristics of the
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b13e0ca6648edb2a6974012540176df7
https://doi.org/10.1186/s13098-023-01028-7
Zobrazit plný text záznamu
8
Akademický článek
The emergence of young children's tolerance for inequality: With age, children stop showing numerically sensitive fairness.
Autor: Chernyak N; Department of Cognitive Sciences, University of California, Irvine, Irvine, CA 92617, USA. Electronic address: nadia.chernyak@uci.edu.
Publikováno v: Journal of experimental child psychology [J Exp Child Psychol] 2024 Feb; Vol. 238, pp. 105785. Date of Electronic Publication: 2023 Oct 03.
Zobrazit plný text záznamu
9
Akademický článek
A counting intervention promotes fair sharing in preschoolers.
Autor: Chernyak N; Department of Cognitive Sciences, University of California-Irvine, Irvine, California, USA., Harris PL; Graduate School of Education, Harvard University, Cambridge, Massachusetts, USA., Cordes S; Department of Psychology and Neuroscience, Boston College, Chestnut Hill, Massachusetts, USA.
Publikováno v: Child development [Child Dev] 2022 Sep; Vol. 93 (5), pp. 1365-1379. Date of Electronic Publication: 2022 Apr 27.
Zobrazit plný text záznamu
10
Akademický článek
Development and application of an in vitro assay to assess target-independent B-cell activation by targeted TLR7 immune agonists.
Autor: Chen Y; Merck & Co. Inc., Rahway, NJ, USA., Zhou S; Merck & Co. Inc., Rahway, NJ, USA., Pradhan K; Merck & Co. Inc., Rahway, NJ, USA., Chernyak N; Merck & Co. Inc., Rahway, NJ, USA., Kofman E; Merck & Co. Inc., Rahway, NJ, USA., Zhang F; Merck & Co. Inc., Rahway, NJ, USA., Kim SY; Merck & Co. Inc., Rahway, NJ, USA., Seghezzi W; Merck & Co. Inc., Rahway, NJ, USA., Willingham A; Merck & Co. Inc., Rahway, NJ, USA., Seganish WM; Merck & Co. Inc., Rahway, NJ, USA., Bhagwat B; Merck & Co. Inc., Rahway, NJ, USA., Han JH; Merck & Co. Inc., Rahway, NJ, USA. Electronic address: jin-hwan.han@merck.com.
Publikováno v: Journal of immunological methods [J Immunol Methods] 2023 Nov; Vol. 522, pp. 113553. Date of Electronic Publication: 2023 Sep 01.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje